These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 31062927)

  • 41. Transcatheter Aortic Valve Implantation in High-Risk/Inoperable Patients: Repositionable versus Non-Repositionable Self-Expanding Valve.
    Veulemans V; Sötemann DB; Kleinebrecht L; Keymel S; Jung C; Zeus T; Kelm M; Westenfeld R
    J Heart Valve Dis; 2017 Jul; 26(4):405-412. PubMed ID: 29302939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings.
    Bagur R; Rodés-Cabau J; Gurvitch R; Dumont É; Velianou JL; Manazzoni J; Toggweiler S; Cheung A; Ye J; Natarajan MK; Bainey KR; DeLarochellière R; Doyle D; Pibarot P; Voisine P; Côté M; Philippon F; Webb JG
    JACC Cardiovasc Interv; 2012 May; 5(5):540-551. PubMed ID: 22625193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Propensity-score-adjusted comparison of Evolut vs. Portico devices for transcatheter aortic valve implantation.
    Giordano A; Corcione N; Ferraro P; Pieri P; Avellino R; Frati G; De Persio G; Altamura L; Tomai F; Biondi-Zoccai G
    J Cardiovasc Med (Hagerstown); 2019 May; 20(5):351-357. PubMed ID: 30676494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcatheter Replacement of Failed Bioprosthetic Valves: Large Multicenter Assessment of the Effect of Implantation Depth on Hemodynamics After Aortic Valve-in-Valve.
    Simonato M; Webb J; Kornowski R; Vahanian A; Frerker C; Nissen H; Bleiziffer S; Duncan A; Rodés-Cabau J; Attizzani GF; Horlick E; Latib A; Bekeredjian R; Barbanti M; Lefevre T; Cerillo A; Hernández JM; Bruschi G; Spargias K; Iadanza A; Brecker S; Palma JH; Finkelstein A; Abdel-Wahab M; Lemos P; Petronio AS; Champagnac D; Sinning JM; Salizzoni S; Napodano M; Fiorina C; Marzocchi A; Leon M; Dvir D
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27301396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Importance of Contrast Aortography With Lotus Transcatheter Aortic Valve Replacement: A Post Hoc Analysis From the RESPOND Post-Market Study.
    van Gils L; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Brecker S; Bapat V; Modine T; Soliman OI; Nersesov A; Allocco D; Falk V; Van Mieghem NM
    JACC Cardiovasc Interv; 2018 Jan; 11(2):119-128. PubMed ID: 29348006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low pacemaker incidence with continuous-sutured valves: a retrospective analysis.
    Niclauss L; Delay D; Pfister R; Colombier S; Kirsch M; Prêtre R
    Asian Cardiovasc Thorac Ann; 2017 Jun; 25(5):350-356. PubMed ID: 28530122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term pacemaker dependency and impact of pacing on mortality following transcatheter aortic valve replacement with the LOTUS valve.
    Alasti M; Rashid H; Rangasamy K; Kotschet E; Adam D; Alison J; Gooley R; Zaman S
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):777-782. PubMed ID: 29314625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improvements of Procedural Results With a New-Generation Self-Expanding Transfemoral Aortic Valve Prosthesis in Comparison to the Old-Generation Device.
    Gomes B; Geis NA; Chorianopoulos E; Meder B; Leuschner F; Katus HA; Bekeredjian R
    J Interv Cardiol; 2017 Feb; 30(1):72-78. PubMed ID: 27882613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coronary Access After TAVR.
    Ochiai T; Chakravarty T; Yoon SH; Kaewkes D; Flint N; Patel V; Mahani S; Tiwana R; Sekhon N; Nakamura M; Cheng W; Makkar R
    JACC Cardiovasc Interv; 2020 Mar; 13(6):693-705. PubMed ID: 32192689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study.
    Popma JJ; Reardon MJ; Khabbaz K; Harrison JK; Hughes GC; Kodali S; George I; Deeb GM; Chetcuti S; Kipperman R; Brown J; Qiao H; Slater J; Williams MR
    JACC Cardiovasc Interv; 2017 Feb; 10(3):268-275. PubMed ID: 28183466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of Clinical and Echocardiographic Outcomes After Transcatheter Aortic Valve Implantation With 31-mm CoreValve Versus 34-mm Evolut R Bioprostheses from the STS/ACC TVT Registry.
    Tang GHL; Reardon MJ; Kodali SK; Hermiller JB; Sorajja P; Szeto WY; Zhang A; Popma JJ
    Am J Cardiol; 2019 Oct; 124(7):1091-1098. PubMed ID: 31362879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Real-World Comparison of 1-Year Survival and Expenditures for Transcatheter Aortic Valve Replacements: SAPIEN 3 Versus CoreValve Versus Evolut R.
    Fukuda H; Kiyohara K; Sato D; Kitamura T; Kodera S
    Value Health; 2021 Apr; 24(4):497-504. PubMed ID: 33840427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coronary access after repeat transcatheter aortic valve replacement in patients of small body size: A simulation study.
    Kawamura A; Maeda K; Shimamura K; Yamashita K; Mukai T; Nakamura D; Mizote I; Sakata Y; Miyagawa S
    J Thorac Cardiovasc Surg; 2024 Jul; 168(1):76-85.e8. PubMed ID: 36604286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors predicting and having an impact on the need for a permanent pacemaker after CoreValve prosthesis implantation using the new Accutrak delivery catheter system.
    Muñoz-García AJ; Hernández-García JM; Jiménez-Navarro MF; Alonso-Briales JH; Domínguez-Franco AJ; Fernández-Pastor J; Peña Hernández J; Barrera Cordero A; Alzueta Rodríguez J; de Teresa-Galván E
    JACC Cardiovasc Interv; 2012 May; 5(5):533-539. PubMed ID: 22625192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk Assessment of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation in Patients With Preexisting Right Bundle Branch Block.
    Sugiyama Y; Miyashita H; Yokoyama H; Ochiai T; Shishido K; Jalanko M; Yamanaka F; Vähäsilta T; Saito S; Laine M; Moriyama N
    Am J Cardiol; 2024 Feb; 213():151-160. PubMed ID: 38103766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transcatheter Valve SELECTion in Patients With Right Bundle Branch Block and Impact on Pacemaker Implantations.
    Husser O; Pellegrini C; Kim WK; Holzamer A; Pilgrim T; Toggweiler S; Schäfer U; Blumenstein J; Deuschl F; Rheude T; Joner M; Hilker M; Hengstenberg C; Möllmann H
    JACC Cardiovasc Interv; 2019 Sep; 12(18):1781-1793. PubMed ID: 31537278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Depth of valve implantation, conduction disturbances and pacemaker implantation with CoreValve and CoreValve Accutrak system for Transcatheter Aortic Valve Implantation, a multi-center study.
    Lenders GD; Collas V; Hernandez JM; Legrand V; Danenberg HD; den Heijer P; Rodrigus IE; Paelinck BP; Vrints CJ; Bosmans JM
    Int J Cardiol; 2014 Oct; 176(3):771-5. PubMed ID: 25147076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in atrioventricular conduction and predictors of pacemaker need after percutaneous implantation of the CoreValve®. Aortic valve prosthesis.
    Muñoz-García AJ; Hernández-García JM; Jiménez-Navarro MF; Alonso-Briales JH; Rodríguez-Bailón I; Peña-Hernández J; Fernández-Pastor J; Domínguez-Franco AJ; Barrera-Cordero A; Alzueta-Rodríguez J; de Teresa Galván E
    Rev Esp Cardiol; 2010 Dec; 63(12):1444-51. PubMed ID: 21144405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.